This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Immunitas Therapeutics, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: George Punkosdy: Innovator in Antibody Therapeutics
Introduction
George Punkosdy is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents, his work focuses on innovative solutions for treating various disorders.
Latest Patents
Punkosdy's latest patents include the invention of anti-CD161 antibodies and their uses. This invention relates to anti-CD161 antibodies, pharmaceutical compositions comprising such antibodies, and methods for using these antibodies to treat disorders associated with or mediated by CD161, including certain cancers. Additionally, the invention encompasses expression vectors and host cells for producing these antibodies.
Career Highlights
George Punkosdy is currently associated with Immunitas Therapeutics, Inc., where he continues to advance his research in antibody therapeutics. His work is pivotal in the ongoing quest for effective treatments for challenging medical conditions.
Collaborations
Some of his notable coworkers include Frano Irvine and Emily Rosentrater, who contribute to the collaborative efforts at Immunitas Therapeutics, Inc. Their combined expertise enhances the innovative environment in which they work.
Conclusion
George Punkosdy's contributions to the field of antibody therapeutics exemplify the impact of innovation in medicine. His patents and ongoing research hold promise for future advancements in treating complex diseases.